Financials
- Market Capitalization 995.29 M
- Employee 93
- Founded 2011
- CEO N/A
- Website www.annexonbio.com
- Headquarter Delaware, United States
- FIGI BBG007QVDFG2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.75
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2446 | ABUS Arbutus Biopharma Corporation - Common Stock | 5.17 USD | -0.39% | -0.58% | +17.23% | +40.49% | 1.02 B USD | ||
| 2448 | WVE Wave Life Sciences Ltd. - Ordinary Shares | 5.16 USD | -1.34% | -2.82% | -11.64% | -27.93% | 1.02 B USD | ||
| 2466 | GERN Geron Corporation - Common Stock | 1.53 USD | 0.00% | -1.92% | +6.25% | +6.25% | 982.98 M USD | ||
| 2486 | DSGN Design Therapeutics, Inc. - Common Stock | 15.25 USD | -2.18% | -2.62% | +27.72% | +169.91% | 954.37 M USD |